Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

368 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of Urea-Based Inhibitors of the Dopamine Transporter Using the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis.
Ashraf-Uz-Zaman M, Ji G, Tidwell D, Yin L, Thakolwiboon S, Pan J, Junell R, Griffin Z, Shahi S, Barthels D, Sajib MS, Trippier PC, Mikelis CM, Das H, Avila M, Neugebauer V, German NA. Ashraf-Uz-Zaman M, et al. Among authors: shahi s. ACS Chem Neurosci. 2022 Jan 19;13(2):217-228. doi: 10.1021/acschemneuro.1c00647. Epub 2022 Jan 3. ACS Chem Neurosci. 2022. PMID: 34978174 Free PMC article.
Design, synthesis and structure-activity relationship study of novel urea compounds as FGFR1 inhibitors to treat metastatic triple-negative breast cancer.
Ashraf-Uz-Zaman M, Shahi S, Akwii R, Sajib MS, Farshbaf MJ, Kallem RR, Putnam W, Wang W, Zhang R, Alvina K, Trippier PC, Mikelis CM, German NA. Ashraf-Uz-Zaman M, et al. Among authors: shahi s. Eur J Med Chem. 2021 Jan 1;209:112866. doi: 10.1016/j.ejmech.2020.112866. Epub 2020 Sep 24. Eur J Med Chem. 2021. PMID: 33039722 Free PMC article.
Correction to "Evaluation of Urea-Based Inhibitors of the Dopamine Transporter Using the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis".
Ashraf-Uz-Zaman M, Ji G, Tidwell D, Yin L, Thakolwiboon S, Pan J, Junell R, Griffin Z, Shahi S, Barthels D, Sajib MS, Trippier PC, Mikelis CM, Das H, Avila M, Neugebauer V, German NA. Ashraf-Uz-Zaman M, et al. Among authors: shahi s. ACS Chem Neurosci. 2022 Nov 2;13(21):3138. doi: 10.1021/acschemneuro.2c00459. Epub 2022 Oct 20. ACS Chem Neurosci. 2022. PMID: 36264675 No abstract available.
Characterization of a Nonselective Opioid Receptor Functional Antagonist: Implications for Development as a Novel Opioid Dependence Medication.
Shahbazi Nia S, Ortiz YT, Zuarth Gonzalez JD, Shamir L, Frimpong-Manson K, Hossain MA, Shahi S, Bandy R, Bhat A, Patel D, Diab H, Thompson J, McMahon LR, Wilkerson JL, German NA. Shahbazi Nia S, et al. Among authors: shahi s. ACS Pharmacol Transl Sci. 2024 Feb 12;7(3):654-666. doi: 10.1021/acsptsci.3c00262. eCollection 2024 Mar 8. ACS Pharmacol Transl Sci. 2024. PMID: 38481688
Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration.
Tusch E, Ryom L, Pelchen-Matthews A, Mocroft A, Elbirt D, Oprea C, Günthard HF, Staehelin C, Zangerle R, Suarez I, Vehreschild JJ, Wit F, Menozzi M, d'Arminio Monforte A, Spagnuolo V, Pradier C, Carlander C, Suanzes P, Wasmuth JC, Carr A, Petoumenos K, Borgans F, Bonnet F, De Wit S, El-Sadr W, Neesgaard B, Jaschinski N, Greenberg L, Hosein SR, Gallant J, Vannappagari V, Young L, Sabin C, Lundgren J, Peters L, Reekie J; D:A:D cohort study; RESPOND cohort study. Tusch E, et al. Clin Infect Dis. 2024 Apr 26:ciae228. doi: 10.1093/cid/ciae228. Online ahead of print. Clin Infect Dis. 2024. PMID: 38663013
368 results